Epstein Secrets

Partner EQT Partners Germany Beteiligungsberatung GmbH Erik A. Brenninkmeijer Chairman of the Supervisory Board COFRA Holding AG Switzerland Maurice Brenninkmeijer Director C&A Netherlands Jim Breyer Partner Accel Partners USA Samir Brikho Chief Executive Officer AMEC Plc United Kingdom Sergey Briley

Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, P

Partner EQT Partners Germany Beteiligungsberatung GmbH Erik A. Brenninkmeijer Chairman of the Supervisory Board COFRA Holding AG Switzerland Maurice Brenninkmeijer Director C&A Netherlands Jim Breyer Partner Accel Partners USA Samir Brikho Chief Executive Officer AMEC Plc United Kingdom Sergey Briley

Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, P

nu Bradford Svein Richard Brandtzaeg Susan Brate Marcus W. Brauchli Sigve Brekke lan Bremmer Berge Brende Marcus Brennecke Erik A. Brenninkmeijer Maurice Brenninkmeijer Jim Breyer Samir Brikho Sergey Brilev Sergey Brin William A. Brindley Scott Brison Clarence James Gamble Professor of Economics and Demography

Minister of Trade of Australia Chief Executive Officer President and Chief Executive Officer Chief Executive Officer Chief Executive Officer Head, Pharma Division Chief Executive Officer, Asset Management Chairman, President and Chief Executive Officer Editor-in-Chief, Magazines Secretary of Foreign Affairs